Skip to content

Genoplan vs MyOme

Genoplan  logo

Genoplan

유전자 정보의 대중화를 선도하는 글로벌 생명공학 기업 제노플랜코리아 입니다

16 employees · est. 2014 · Seoul, Korea South

VS
MyOme logo

MyOme

Helping families understand their DNA and how it impacts their health throughout their lives

45 employees · est. 2017 · Palo Alto, United States

Genoplan is the older company (2014 vs 2017).

Side-by-Side Comparison

Genoplan MyOme
Founded
2014 older 2017
Headquarters
Seoul, Korea South Palo Alto, United States
Employees
16 45
Industry
AI, Analytics, Biotechnology Biotechnology, Life Sciences
Funding Stage
Series C Series B
Total Funding
$27.83M $23.00M
Funding Rounds
5 3
Taxonomy
GenomicsDNA SequencingAI TechnologyPrecision MedicineLifestyleHealth & Wellness +7 DNA AnalysisGenetic HealthBioinformaticsData ScienceMachine LearningHealth Technology +5
Website
genoplan.com myome.com
Genoplan  logo

About Genoplan

As an investor, I have analyzed Genoplan, a South Korean biotechnology startup specializing in DNA testing. Founded in 2014, the company uses saliva samples to conduct genetic analysis and offer personalized lifestyle advice, including diet, health food, workout, and cosmetics recommendations. With...

MyOme logo

About MyOme

MyOme is a biotechnology startup, founded in 2017, with headquarters in the United States. The company's slogan, "Helping families understand their DNA and how it impacts their health throughout their lives," reflects its core mission. MyOme uses the latest technologies to provide families with secu...

Also comparing in this category

Comparing more than these two?

Get Genoplan , MyOme and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Genoplan compare?

A PDF of Genoplan and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Genoplan was founded in 2014, based in Seoul, Korea South, with 16 employees. As an investor, I have analyzed Genoplan, a South Korean biotechnology startup specializing in DNA testing. Founded in 2014, the company uses saliva samples to conduct genetic analysis and offer perso. MyOme was founded in 2017, based in Palo Alto, United States, with 45 employees. MyOme is a biotechnology startup, founded in 2017, with headquarters in the United States. The company's slogan, "Helping families understand their DNA and how it impacts their health throughout their.
Genoplan has raised $27.83M and MyOme $23.00M. Latest stage: Genoplan Series C, MyOme Series B.
Both work in Biotechnology and Life Sciences and list personalized medicine among their focus areas.

Compare Genoplan with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Genoplan on 12 Sep 2024, and MyOme on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout